HER2/CEP17 ratio predicts residual cancer burden after neoadjuvant dual HER2 blockade: real-world data in patients with primary HER2-amplified breast cancer.
Saved in:
| Title: | HER2/CEP17 ratio predicts residual cancer burden after neoadjuvant dual HER2 blockade: real-world data in patients with primary HER2-amplified breast cancer. |
|---|---|
| Authors: | Stolz M; Department of Obstetrics and Gynecology, Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria., Farr A; Department of Obstetrics and Gynecology, Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria., Tendl-Schulz KA; Department of Pathology, Comprehensive Cancer Center, Medical University of Vienna, Waehringer Guertel 18-20, 1090, Vienna, Austria., Frommlet F; Institute of Medical Statistics, Informatics and Intelligent Systems (CeMSIIS), Medical University of Vienna, Vienna, Austria., Reckendorfer H; Institute of Clinical Pathology, Cytology and Microbiology Ltd. Vienna, Dr. Kosak Und Partner - Fachärzte Für Pathologie GmbH, Vienna, Austria., Koperek O; Laboratory Kaserer, Koperek and Beer Ltd., Vienna, Austria., Neudert B; Department of Pathology, Comprehensive Cancer Center, Medical University of Vienna, Waehringer Guertel 18-20, 1090, Vienna, Austria., Marhold M; Department of Medicine I, Division of Oncology, Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria., Heber U; Department of Pathology, Comprehensive Cancer Center, Medical University of Vienna, Waehringer Guertel 18-20, 1090, Vienna, Austria., Exner R; Department of General and Visceral Surgery, Division of Oncology, Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria., Singer CF; Department of Obstetrics and Gynecology, Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria., Bartsch R; Department of Medicine I, Division of Oncology, Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria., Bago-Horvath Z; Department of Pathology, Comprehensive Cancer Center, Medical University of Vienna, Waehringer Guertel 18-20, 1090, Vienna, Austria. zsuzsanna.horvath@meduniwien.ac.at. |
| Source: | Virchows Archiv : an international journal of pathology [Virchows Arch] 2025 Nov; Vol. 487 (5), pp. 1015-1024. Date of Electronic Publication: 2025 Aug 05. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Springer International Country of Publication: Germany NLM ID: 9423843 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1432-2307 (Electronic) Linking ISSN: 09456317 NLM ISO Abbreviation: Virchows Arch Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 40762650 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: HER2/CEP17 ratio predicts residual cancer burden after neoadjuvant dual HER2 blockade: real-world data in patients with primary HER2-amplified breast cancer. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Stolz+M%22">Stolz M</searchLink>; Department of Obstetrics and Gynecology, Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria.<br /><searchLink fieldCode="AU" term="%22Farr+A%22">Farr A</searchLink>; Department of Obstetrics and Gynecology, Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria.<br /><searchLink fieldCode="AU" term="%22Tendl-Schulz+KA%22">Tendl-Schulz KA</searchLink>; Department of Pathology, Comprehensive Cancer Center, Medical University of Vienna, Waehringer Guertel 18-20, 1090, Vienna, Austria.<br /><searchLink fieldCode="AU" term="%22Frommlet+F%22">Frommlet F</searchLink>; Institute of Medical Statistics, Informatics and Intelligent Systems (CeMSIIS), Medical University of Vienna, Vienna, Austria.<br /><searchLink fieldCode="AU" term="%22Reckendorfer+H%22">Reckendorfer H</searchLink>; Institute of Clinical Pathology, Cytology and Microbiology Ltd. Vienna, Dr. Kosak Und Partner - Fachärzte Für Pathologie GmbH, Vienna, Austria.<br /><searchLink fieldCode="AU" term="%22Koperek+O%22">Koperek O</searchLink>; Laboratory Kaserer, Koperek and Beer Ltd., Vienna, Austria.<br /><searchLink fieldCode="AU" term="%22Neudert+B%22">Neudert B</searchLink>; Department of Pathology, Comprehensive Cancer Center, Medical University of Vienna, Waehringer Guertel 18-20, 1090, Vienna, Austria.<br /><searchLink fieldCode="AU" term="%22Marhold+M%22">Marhold M</searchLink>; Department of Medicine I, Division of Oncology, Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria.<br /><searchLink fieldCode="AU" term="%22Heber+U%22">Heber U</searchLink>; Department of Pathology, Comprehensive Cancer Center, Medical University of Vienna, Waehringer Guertel 18-20, 1090, Vienna, Austria.<br /><searchLink fieldCode="AU" term="%22Exner+R%22">Exner R</searchLink>; Department of General and Visceral Surgery, Division of Oncology, Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria.<br /><searchLink fieldCode="AU" term="%22Singer+CF%22">Singer CF</searchLink>; Department of Obstetrics and Gynecology, Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria.<br /><searchLink fieldCode="AU" term="%22Bartsch+R%22">Bartsch R</searchLink>; Department of Medicine I, Division of Oncology, Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria.<br /><searchLink fieldCode="AU" term="%22Bago-Horvath+Z%22">Bago-Horvath Z</searchLink>; Department of Pathology, Comprehensive Cancer Center, Medical University of Vienna, Waehringer Guertel 18-20, 1090, Vienna, Austria. zsuzsanna.horvath@meduniwien.ac.at. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%229423843%22">Virchows Archiv : an international journal of pathology</searchLink> [Virchows Arch] 2025 Nov; Vol. 487 (5), pp. 1015-1024. <i>Date of Electronic Publication: </i>2025 Aug 05. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Springer+International%22">Springer International </searchLink><i>Country of Publication: </i>Germany <i>NLM ID: </i>9423843 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1432-2307 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2209456317%22">09456317 </searchLink><i>NLM ISO Abbreviation: </i>Virchows Arch <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=40762650 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1007/s00428-025-04203-5 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 1015 Titles: – TitleFull: HER2/CEP17 ratio predicts residual cancer burden after neoadjuvant dual HER2 blockade: real-world data in patients with primary HER2-amplified breast cancer. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Stolz M – PersonEntity: Name: NameFull: Farr A – PersonEntity: Name: NameFull: Tendl-Schulz KA – PersonEntity: Name: NameFull: Frommlet F – PersonEntity: Name: NameFull: Reckendorfer H – PersonEntity: Name: NameFull: Koperek O – PersonEntity: Name: NameFull: Neudert B – PersonEntity: Name: NameFull: Marhold M – PersonEntity: Name: NameFull: Heber U – PersonEntity: Name: NameFull: Exner R – PersonEntity: Name: NameFull: Singer CF – PersonEntity: Name: NameFull: Bartsch R – PersonEntity: Name: NameFull: Bago-Horvath Z IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 11 Text: 2025 Nov Type: published Y: 2025 Identifiers: – Type: issn-electronic Value: 1432-2307 Numbering: – Type: volume Value: 487 – Type: issue Value: 5 Titles: – TitleFull: Virchows Archiv : an international journal of pathology Type: main |
| ResultId | 1 |
